A systematic review and meta‐analysis of interventions to delabel low‐risk penicillin allergies with consideration for sex and gender
British Journal of Clinical Pharmacology · 2025
DOI: 10.1111/bcp.16366 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift British Journal of Clinical Pharmacology, 2025. Verfasst von Mira Maximos und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, University of Waterloo, Kitchener, ON, Canada. Hauptthemen laut MEDLINE: Drug Hypersensitivity, Penicillins, Anti-Bacterial Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Aims
Sex and gender may influence penicillin allergy label (PAL) prevalence and outcomes. This review evaluates the effectiveness and safety of direct delabelling (DD) and oral challenge (OC) for low‐risk patients and examines sex and gender differences in reporting and outcomes.
Methods
We searched PubMed, Database of Abstracts of Reviews and Effects, ClinicalTrials.gov , Cochrane Database of Systematic Reviews, International Pharmaceutical Abstracts, medRxiv, Ovid MEDLINE, and Ovid EMBASE until February 2024 for studies including DD or OC compared to no intervention, skin testing or other methods. Two reviewers assessed quality. Meta‐analyses were conducted, and subgroup analyses were carried out if I 2 > 75%. Descriptive data was analysed using NVivo 14 and reported narratively.
Results
From 1046 screened studies, 28 met inclusion criteria (two RCTs, 26 quasi‐experimental studies). Sex at baseline was reported in 86% of studies, with 61% females: 18% disaggregated outcomes by sex with a female mean delabelling rate of 66%. Gender variables were not reported. OC was not found to be more or less as effective comparaed to skin testing in RCTs (risk ratio [RR] 1.04; 95% confidence interval [CI] 0.95, 1.13, I 2 = 74%). DD interventions had a 27% delabelling rate (95% CI 10%, 50%, I 2 = 96%), with nursing staff achieving 29% (95% CI 15%, 47%, I 2 = 63%) and allergists/immunologists 6% (95% CI 0.00, 0.00, I 2 = 20%). Quasi‐experimental studies reported 90% delabelling for OC, with 59% by allergists/immunologists and 90% by pharmacists. Adverse events averaged 4% and were non‐severe.
Conclusions
DD and OC are effective for delabelling low‐risk penicillin allergies. Comprehensive data is lacking on sex and gender differences, indicating a need for further research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, University of Waterloo, Kitchener, ON, Canada.
- Women's College Hospital, Toronto, ON, Canada.
- Schulich School of Medicine and Dentistry, London, ON, Canada.
ORCID-Profile: Mira Maximos, John-Michael Gamble
Zitieren
APA
Maximos, M., Pelletier, R., Elsayed, S., Maxwell, C. J., Houle, S. K. D., McConnell, B., & Gamble, J. M. (2025). A systematic review and meta‐analysis of interventions to delabel low‐risk penicillin allergies with consideration for sex and gender. British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.16366
Vancouver
Maximos M, Pelletier R, Elsayed S, Maxwell CJ, Houle SKD, McConnell B, et al. A systematic review and meta‐analysis of interventions to delabel low‐risk penicillin allergies with consideration for sex and gender. British Journal of Clinical Pharmacology. 2025. doi:10.1111/bcp.16366
BibTeX
@article{Maximos2025,
author = {Maximos, Mira and Pelletier, Ryan and Elsayed, Sameer and Maxwell, Colleen J and Houle, Sherilyn K D and McConnell, Brie and Gamble, John-Michael},
title = {A systematic review and meta‐analysis of interventions to delabel low‐risk penicillin allergies with consideration for sex and gender},
journal = {British Journal of Clinical Pharmacology},
year = {2025},
doi = {10.1111/bcp.16366}
}
EUVIMED